-
Alnylam eyes quickie givosiran filing after hitting interim goal
fiercebiotech
September 28, 2018
Alnylam is set to file for accelerated FDA approval of givosiran on the strength of interim data from a phase 3 trial.
-
FDA piloting innovative clinical trial designs
europeanpharmaceuticalreview
September 05, 2018
The US FDA is looking to begin a new phase of innovative clinical trial designs…
-
Portland immunotherapy startup tops $10M in funding as it launches first clinical trial
firstwordpharma
May 30, 2018
Emmanuel Akporiaye, founder of Veana Therapeutics, said the start-up raised its first venture funding, a $542 000 seed round that brings its total funding to more than $10 million, reported GeekWire
-
Acute Pain - 2018 Pipeline Highlights
biospace
April 20, 2018
Acute Pain Pipeline Highlights - 2018, provides the most up-to-date information on key pipeline products in the global Acute Pain market.
-
Feinstein, NIH launch groundbreaking clinical trial for new lupus medication
biospectrumasia
April 08, 2018
Trial examines use of synthetic endocannabinoid mimetic with no psychotropic properties to treat lupus inflammation
-
MYR Pharma Completes Clinical Trial of Myrcludex B in Chronic Hepatitis Delta
biospace
March 13, 2018
MYR Pharma GmbH today announced the completion of its MYR 202 clinical trial
-
Caligor Holdco, LLC, Leader in Strategic Clinical Trial Services, Acquires The Coghlan Group
prnasia
November 17, 2017
Caligor Holdco, LLC., announced today the acquisition of The Coghlan Group, a leading materials management service company for clinical trials.
-
First made-in-India ‘digital pill’ to undergo clinical trial for diabetes
expressbpd
November 16, 2017
The #WeDiDiT (Wellthy Digital Diabetes Therapy) trial is all set to prove the efficacy of its 16-week structured diabetes management programme delivered through a mobile app.
-
MD Anderson, Daiichi Sankyo collaborate to accelerate development of acute myeloid leukemia therapie
pharmaasia
September 18, 2017
The collaboration will launch multiple phase 1 and 2 clinical trials conducted by MD Anderson with the aim of expediting delivery of new therapies.
-
Clinical trial matching platform raises $11M backed by Merck’s tech fund
fiercebiotech
September 14, 2017
Antidote, as one of them, just recently raised $11 million in a financing round led by Merck Global Health Innovation (GHI) Fund.